Know Cancer

or
forgot password

The Molecular Characterization of Multiple Myeloma at Relapse


N/A
18 Years
N/A
Open (Enrolling)
Both
Multiple Myeloma

Thank you

Trial Information

The Molecular Characterization of Multiple Myeloma at Relapse


Inclusion Criteria:



- patients newly diagnosed with multiple myeloma and at the same time eligible for high
dose chemotherapy and autologous stem cell transplantation

- patients with multiple myeloma experiencing relapse after high dose chemotherapy and
autologous stem cell transplantation

Exclusion Criteria:

- for newly diagnosed patients: age or comorbidity preventing high dose chemotherapy
and autologous stem cell transplantation,

- for all patients: age below 18, physical or psychological incapability to give an
informed consent.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Molecular characteristics (by FISH, SNP, GEP, miRNA)

Outcome Time Frame:

0-3 years

Safety Issue:

No

Principal Investigator

N Emil U Hermansen, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Rigshospitalet, Denmark

Authority:

Denmark: Danish Dataprotection Agency

Study ID:

959593931/Emil Hermansen

NCT ID:

NCT00639054

Start Date:

March 2008

Completion Date:

January 2016

Related Keywords:

  • Multiple Myeloma
  • classification
  • diagnosis
  • genetics
  • mortality
  • pathology
  • Multiple Myeloma
  • Neoplasms, Plasma Cell

Name

Location